Related Experiment Video
Updated: Jun 16, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[Clinical utility of atazanavir]
Esteban Ribera Pascuet1, Adrià Curran
1Servicio de Enfermedades Infecciosas, Hospital Universitari Vall d'Hebron, Barcelona, España. eribera@vhebron.net
Enfermedades Infecciosas Y Microbiologia Clinica
|February 2, 2010
Summary
Atazanavir (ATV) offers convenient dosing, good tolerability, and an excellent metabolic profile, making it a valuable protease inhibitor (PI) for HIV treatment. Its effectiveness is demonstrated in various treatment scenarios, including initial therapy and simplification strategies.
Area of Science:
- Pharmacology and Therapeutics
- Antiretroviral Therapy
- HIV/AIDS Management
Context:
- Atazanavir (ATV) is a protease inhibitor (PI) with favorable dosing, tolerability, and metabolic characteristics.
- It exhibits properties similar to non-nucleoside reverse transcriptase inhibitors but retains the genetic barrier of PIs.
- ATV is approved for various HIV treatment situations, including initial therapy, simplification, and rescue treatment.
Purpose:
- To evaluate the efficacy and tolerability of Atazanavir (ATV) in different HIV treatment regimens.
- To assess ATV's role in treatment simplification, toxicity-driven changes, and first-line rescue therapy.
- To compare ATV with other antiretrovirals like lopinavir/ritonavir and efavirenz.
Summary:
- Boosted ATV (with ritonavir) is approved in Europe for all clinical situations and has shown comparable efficacy to lopinavir/ritonavir and efavirenz in treatment-naïve patients.
- ATV is effective for simplifying treatment or switching due to toxicity, maintaining viral control with improved lipid profiles and reduced cardiovascular risk.
- Non-boosted ATV (400 mg/d) may benefit specific patient groups, and ATV is effective in first-line rescue treatments, improving compliance due to its simplicity and tolerability.
Impact:
- Atazanavir is a highly prescribed PI in the USA and is increasingly recognized in Europe for its versatility in HIV management.
- The drug's favorable profile supports long-term HIV management, addressing factors like tolerability, cardiovascular risk, and patient lifestyle adaptability.
- ATV plays a significant role in improving patient outcomes and adherence in the evolving landscape of HIV infection survival.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...

